Opposing effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on blood lipids in healthy humans

American Journal of Clinical Nutrition

Volumn 80, Issue 3, 2004, Pages 614-620

  Tricon, Sabine ^a   Burdge, Graham C ^b   Kew, Samantha ^a   Banerjee, Tapati ^b   Russell, Jennifer J ^b   Jones, Emma L ^a   Grimble, Robert F ^b   Williams, Christine M ^a   Yaqoob, Parveen ^a   Calder, Philip C ^b  

^a UNIVERSITY OF READING   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Cholesterol; Conjugated linoleic acid; High density lipoprotein; Low density lipoprotein; Triacylglycerol

Indexed keywords

CONJUGATED LINOLEIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; CHOLESTEROL; INSULIN; LIPOPROTEIN;

ARTICLE; BODY COMPOSITION; CHOLESTEROL BLOOD LEVEL; CIS TRANS ISOMERISM; CONJUGATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE MARKER; HOMEOSTASIS; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MALE; NORMAL HUMAN; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL; ADIPOSE TISSUE; ADULT; BLOOD; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; GLUCOSE BLOOD LEVEL; ISOMERISM; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

ANIMALIA;

ADIPOSE TISSUE; ADULT; BLOOD GLUCOSE; BODY COMPOSITION; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; HUMANS; INSULIN; INSULIN RESISTANCE; ISOMERISM; LINOLEIC ACIDS, CONJUGATED; LIPOPROTEINS; MALE; MIDDLE AGED; TRIGLYCERIDES;

EID: 4544259614     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/80.3.614     Document Type: Article

References (33)

1. Ip C, Chin SF, Scimeca JA, Pariza MW. Mammary cancer prevention by conjugated dienoic derivative of linoleic acid. Cancer Res 1991;51:6118-24.
2. Ip C, Singh M, Thompson HJ, Scimeca JA. Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rat. Cancer Res 1994;54:1212-5.
3. Ip C, Scimeca JA, Thompson H. Effect of timing and duration of dietary conjugated linoleic acid on mammary cancer prevention. Nutr Cancer 1995;24:241-7.
4. Ip C, Scimeca JA. Conjugated linoleic acid and linoleic acid are distinctive modulators of mammary carcinogenesis. Nutr Cancer 1997;27:131-5.
5. Ip C, Banni S, Angioni E, et al. Conjugated linoleic acid-enriched butter fat alters mammary gland morphogenesis and reduces cancer risk in rats. J Nutr 1999;129:2135-42.
6. Lee KN, Kritchvesky D, Pariza MW. Conjugated linoleic acid and atherosclerosis in rabbits. Atherosclerosis 1994;108:19-25.
7. Nicolosi RJ, Rogers EJ, Kritchevsky D, Scimeca JA, Huth PJ. Dietary conjugated linoleic acid reduces plasma lipoproteins and early aortic atherosclerosis in hypercholesterolemic hamsters. Artery 1997;22:266-77.
8. Roche HM, Noone E, Nugent AP, Gibney MJ. Conjugated linoleic acid: a novel therapeutic nutrient? Nutr Res Rev 2001;14:173-87.
9. Munday JS, Thompson KG, James KAC. Dietary conjugated linoleic acids promote fatty streak formation in the C57BL/6 mouse atherosclerosis model. Br J Nutr 1999;81:251-5.
10. Kritchevsky D, Tepper SA, Wright S, Tso P, Czamecki SK. Influence of conjugated linoleic acid on establishment and progression of atherosclerosis in rabbits. J Am Coll Nutr 2000;19:472S-7S.
11. Atkinson RL. Conjugated linoleic acid for altering body composition and treating obesity. In: Yurawecz MP, Mossoba MM, Kramer JKG, Pariza MW, Nelson GJ, eds. Advances in conjugated linoleic acid research. Champaign, IL: AOCS Press, 1999:348-53.
12. Zambell KL, Keim NL, Van Loan MD, et al. Conjugated linoleic acid supplementation in humans: effects on body composition and energy expenditure. Lipids 2000;35:777-82.
13. Noone EJ, Roche HM, Nugent AP, Gibney MJ. The effect of dietary supplementation using isomeric blends of conjugated linoleic acid on lipid metabolism in healthy human subjects. Br J Nutr 2002;88:243-51.
14. Kreider RB, Ferreira MP, Greenwood M, Wilson M, Almada AL. Effects of conjugated linoleic acid supplementation during resistance training on body composition, bone density, strength, and selected hematological markers. J Strength Cond Res 2002;16:325-34.
15. Petridou A, Mougios V, Sagredos A. Supplementation with CLA: isomer incorporation into serum lipids and effect on body fat of women. Lipids 2003;38:805-11.
16. Blankson H, Stakkestad JA, Fagertun H, Thom E, Wadstein J, Gudmundsen O. Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J Nutr 2000;130:2943-8.
17. Mougios V, Matsakas A, Petridou A, et al. Effect of supplementation with conjugated linoleic acid on human serum lipids and body fat. J Nutr Biochem 2001;12:585-94.
18. Smedman A, Vessby B. Conjugated linoleic acid supplementation in humans: metabolic effects. Lipids 2001;36:773-81.
19. Riserus U, Berglund L, Vessby B. Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in obese middle-aged men with signs of the metabolic syndrome: a randomised controlled trial. Int J Obes Relat Metab Disord 2001;25:1129-35.
20. Benito P, Nelson GJ, Kelley DS, Bartolini G, Schmidt PC, Simon V. The effect of conjugated linoleic acid on plasma lipoproteins and tissue fatty acid composition in humans. Lipids 2001;36:229-36.
21. Griinari JM, Bauman DE. Biosynthesis of conjugated linoleic acid and its incorporation into meat and milk in ruminants. In: Yurawecz MP, Mossoba MM, Kramer JKG, Pariza MW, Nelson GJ, eds. Advances in conjugated linoleic acid research. Champaign, IL: AOCS Press; 1999:180-99.
22. Pariza MW, Park Y, Cook ME. The biologically active isomers of conjugated linoleic acid. Prog Lipid Res 2001;40:283-98.
23. Riserus U, Brismar K, Arner P, Vessby B. Treatment with dietary trans-10 cis-12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 2002;25:1516-21.
24. Burdge GC, Lupoli B, Russell JJ, et al. Incorporation of cis-9, trans-11 or trans-10, cis-12 conjugated linoleic acid into plasma and cellular lipids in healthy men. J Lipid Res 2004;45:736-41.
25. Lawrence JH, Tobias CA, eds. Advances in biological and medical physics. Vol 4. New York: Academic Press Inc, 1956.
26. Friedewald WT, Levy RI. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultra-centrifuge. Clin Chem 1972;18:499-502.
27. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985;28:412-9.
28. Perseghin G, Caumo A, Caloni M, Testolin G, Luzi L. Incorporation of the fasting FFA concentration into QUICKI improves its association with insulin sensitivity in nonobese individuals. J Clin Endocrinol Metab 2001;86:4776-81.
29. Park Y, Storkson JM, Albright KJ, Liu W, Pariza MW. Evidence that the trans-10,cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids 1999;34:235-41.
30. Gavino VC, Gavino G, Leblanc MJ, Tuchweber B. An isomeric mixture of conjugated linoleic acids but not pure cis-9,trans-11-octadecadienoic acid affects body weight gain and plasma lipids in hamsters. J Nutr 2000;130:27-9.
31. Grover SA, Dorais M, Coupal L. Improving the prediction of cardiovascular risk: interaction between LDL and HDL cholesterol. Epidemiology 2003;14:315-20.
32. Fredenrich A, Bayer P. Reverse cholesterol transport, high density lipoproteins and HDL cholesterol: recent data. Diabetes Metab 2003;29:201-5.
33. Medina EA, Horn WF, Keim NL, et al. Conjugated linoleic acid supplementation in humans: effects on circulating leptin concentrations and appetite. Lipids 2000;35:783-8.